Real-world experience with monthly and quarterly dosing of fremanezumab for the treatment of patients with migraine in Japan

Shiho Suzuki(Dokkyo University), Koichi Hirata(Japan Coal Energy Center), Yasuo Haruyama(Dokkyo Medical University), Keisuke Suzuki(NEC (Japan)), Tomohiko Shiina(Dokkyo Medical University)
Frontiers in Neurology
July 6, 2023
Cited by 48


Related Papers